The relationships between fat-soluble vitamin deficiency and childhood obesity risk

Fang Zhou1, Xiaofang Li2, Li Zhu1

  • 1Department of Paediatrics, Traditional Chinese Medical Hospital of Zhuji, Zhejiang, China.

Insights

This study found a strong link between fat-soluble vitamin deficiency and childhood obesity. Vitamin D deficiency was particularly common in obese children, increasing their risk.

Area of Science:

  • Pediatric Nutrition
  • Endocrinology
  • Public Health

Background:

  • Obesity is a growing global health concern in children.
  • Fat-soluble vitamins (A, D, E, K) play crucial roles in overall health.
  • Understanding nutrient status in pediatric obesity is vital for intervention strategies.

Purpose of the Study:

  • To investigate the relationship between serum levels of fat-soluble vitamins (A, D, E, K) and obesity indicators in children.
  • To compare vitamin levels between obese children and a healthy control group.
  • To analyze age-specific associations between vitamin deficiencies and pediatric obesity.

Main Methods:

  • A cross-sectional study involving 208 children, divided into obese (n=104) and control (n=104) groups.
  • Serum vitamin concentrations measured using highly sensitive liquid chromatography-tandem mass spectrometry (LC-MS).
  • Age-stratified analyses performed for BMI, body fat percentage, and waist-to-height ratio.

Main Results:

  • Vitamin D deficiency was significantly more prevalent in obese children (62.50%) compared to controls (28.85%, P < 0.001).
  • Vitamin D deficiency was associated with obesity in children aged 6-11 years (OR = 3.329) and adolescents aged 11-17 years (OR = 4.890).

Conclusions:

  • A significant association exists between fat-soluble vitamin deficiency and pediatric obesity.
  • Vitamin D deficiency is a key finding in obese children and adolescents.
  • These results underscore the importance of assessing vitamin status in the management of childhood obesity.
Abstract

Related Concept Videos

Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced in our...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...